The Nuclear Vitamin D Receptor: Biological and Molecular Regulatory Properties Revealed
- 1 March 1998
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 13 (3) , 325-349
- https://doi.org/10.1359/jbmr.1998.13.3.325
Abstract
No abstract availableThis publication has 220 references indexed in Scilit:
- ERC-55, a Binding Protein for the Papilloma Virus E6 Oncoprotein, Specifically Interacts with Vitamin D Receptor among Nuclear ReceptorsBiochemical and Biophysical Research Communications, 1997
- A 65-Kilodalton Nuclear Protein Binds to the Human Vitamin D Receptor: A Bacterial-Expressed Histidine-Tagged Receptor StudyBiochemical and Biophysical Research Communications, 1997
- Vitamin D Receptor Allelesb,a, andT: Risk Factors for Sporadic Primary Hyperparathyroidism (HPT) but Not HPT of Uremia or MEN 1Biochemical and Biophysical Research Communications, 1997
- 1,25-Dihydroxyvitamin D3 Inhibits Osteocalcin Expression in Mouse through an Indirect MechanismJournal of Biological Chemistry, 1997
- Biologic effects of topical calcipotriol (MC 903) treatment in psoriatic skinJournal of the American Academy of Dermatology, 1997
- A transcriptional co-repressor that interacts with nuclear hormone receptorsNature, 1995
- 1,25-Dihydroxyvitamin D3 Regulation of Myocardial Growth and c-myc Levels in the Rat HeartBiochemical and Biophysical Research Communications, 1995
- Phosphorylation of the Human 1,25-Dihydroxyvitamin D3 Receptor by cAMP-Dependent Protein-Kinase, In Vitro, and in Transfected COS-7 CellsBiochemical and Biophysical Research Communications, 1993
- A novel approach for the evaluation and treatment of psoriasis: Oral or topical use of 1,25-dihydroxyvitamin D3 can be a safe and effective therapy for psoriasisJournal of the American Academy of Dermatology, 1988
- Basic and Clinical Concepts Related to Vitamin D Metabolism and ActionNew England Journal of Medicine, 1977